COVID Therapies


Local Doctor Says Covid-19 Patients Saw Results with Glutathione

Dr. Richard Horowitz, Medical Director of Hudson Valley Healing Arts Center in New York State, administered to his Covid-19 patients.  Web MD defines glutathione “as an important  antioxidant found in your body” combatting free radicals that can damage your body's cells.  It also has detoxification and immune support benefits. Glutathione is not only known as the Master Anti-Oxidant, but is also known as a powerful Anti-Viral. With Dr. Horowitz’ patients, their shortness of breath improved, often in as little as one hour. Another small case study titled, “Efficacy of glutathione therapy in relieving dyspnea associated with COVID-19 pneumonia: A report of 2 cases” found potential for glutathione as therapy for Covid-19 symptoms.

A New York Post headline on May 9 read “New York mom with coronavirus saved by medical-student son’s quick thinking.”  Dr. Horowotiz had recommended glutathione for his sister’s Lyme disease.  It saved this mom’s life.

A PubMed is the government database search engine of references and abstracts on life sciences and biomedical topics. A search on Pub Med of “glutathione” and “anti-viral” returns 5,239 results.  There are compelling reasons and much research to consider glutathione as a potential therapy for Covid-19.

Glutathione increase by the n‐butanoyl glutathione derivative (GSH‐C4) inhibits viral replication and induces a predominant Th1 immune profile in old mice infected with influenza virus

Endogenous Deficiency of Glutathione as the most likely cause of serious manifestations and death in Covid-19


Hyperbaric Oxygen Therapy (HBOT) – improvements, improvements, improvements!

Dr. Paul Harch, emergency medicine clinician and director of the University Medical Center Hyperbaric Medicine Department and Clinical Professor of Medicine, Section of Emergency Medicine at LSU School of Medicine, New Orleans, looked at the results of using hyperbaric oxygen for Covid-19 pneumonia and respiratory failure. Within three days of therapy, lung fluid was greatly reduced and more normal lung tissue appeared.  Blood oxygen levels elevated immediately following each session.

A recent article in the Journal of Wound Care (Hyperbaric oxygen therapy in preventing mechanical ventilation in COVID-19 patients: a retrospective case series) concluded:  “This small sample of patients exhibited dramatic improvement with HBOT. Most importantly, HBOT potentially prevented the need for mechanical ventilation.”

A letter to the editor of Cell Stress and Chaperones, “Covid-19, acute respiratory distress syndrome (ARDS) and hyperbaric oxygen therapy (HBOT): what is the link?cited no less than 35 recent studies in support of HBOT as a useful tool for improving conditions of Covid-19. 


Ozone Therapy (OT) – and more improvements!

In this short video, Dr. Robert Rowen discussed ozone therapy for recovery during first treatment for Covid-19 patient. He found that most respiratory signs greatly diminished or were nonexistent by end of therapy.

A research article published May 2020 in Antioxidant Journal, Potential Cytoprotective Activity of Ozone Therapy in SARS-CoV-2/COVID-19, found a number of potential therapeutic actions of Ozone, including a cell protective effect and a blockage of viral replication.

This month’s American Journal of Case Reports article, “Potential Role of Oxygen-Ozone Therapy in Treatment of Covid-19 Pneumonia” provided further support for Ozone Therapy benefits such as decrease in inflammatory markers and avoiding usage of mechanical ventilation.

About MAMM's Collaborative Communication Committee